首页> 美国卫生研究院文献>Marine Drugs >Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis
【2h】

Attenuating Effects of Dieckol on High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease by Decreasing the NLRP3 Inflammasome and Pyroptosis

机译:通过降低NLRP3炎症和辐射虫病通过减少高脂饮食诱发非酒精性脂肪肝病的衰减

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nonalcoholic fatty liver disease (NAFLD), which promotes serious health problems, is related to the increase in the nucleotide-binding oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome and pyroptosis by a high-fat diet (HFD). Whether dieckol (DK), a component of Ecklonia cava extracts (ECE), attenuated NAFLD in an HFD-induced NAFLD animal model was evaluated. The expression of high mobility group box 1/Toll-like receptor 4uclear factor-κB, which initiated the NLRP3 inflammasome, was increased in the liver of HFD-fed animals and significantly decreased with ECE or DK administration. The expression of NLRP3/ASC/caspase-1, which are components of the NLRP3 inflammasome, and the number of pyroptotic cells were increased by HFD and decreased with ECE or DK administration. The accumulation of triglycerides and free fatty acids in the liver was increased by HFD and decreased with ECE or DK administration. The histological NAFLD score was increased by HFD and decreased with ECE or DK administration. The expression of lipogenic genes (FASN, SREBP-2, PPARγ, and FABP4) increased and that of lipolytic genes (PPARα, CPT1A, ATGL, and HSL) was decreased by HFD and attenuated with ECE or DK administration. In conclusion, ECE or DK attenuated NAFLD by decreasing the NLRP3 inflammasome and pyroptosis.
机译:促进严重健康问题的非酒精性脂肪肝疾病(NAFLD)与核苷酸结合寡聚化结构域样受体家族的增加有关,含有3(NLRP3)涌入的吡啶结构域并通过高脂饮食(HFD) 。 Dieckol(DK)是否是Ecklonia cava提取物(ECE)的组分,评估了HFD诱导的NAFLD动物模型中的减毒NAFLD。在HFD-FED动物的肝脏中增加了高迁移率组箱1 / Toll样受体4 /核因子-κB的含量,其在肝脏肝脏中增加,并且随着ECE或DK给药显着降低。 NLRP3 / ASC / caspase-1的表达,其是NLRP3炎症组的组分,并且通过HFD增加了糊化细胞的数量,并用ECE或DK给药减少。通过HFD增加肝脏中甘油三酯和游离脂肪酸的积累,并用ECE或DK施用减少。通过HFD增加组织学NAFLD评分并随ECE或DK施用减少。通过HFD增加脂质基因(FASN,SREBP-2,PPARγ和FABP4)的表达和脂肪溶解基因(PPARα,CPT1A,ATGL和HSL)和衰减eCE或DK施用。总之,通过减少NLRP3炎症和肉瘤菌和烧烤剂,eCE或DK减弱NAFLD。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号